Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager.

Aidan A PucchioMaya Heled AkivaHelena EvangeliouJesse PapenburgMarina I Salvadori

Published in: Pediatric nephrology (Berlin, Germany) (2022)

While vaccination is the safest and most effective way to prevent morbidity from COVID-19, clinicians should be aware that rhabdomyolysis could be a rare but treatable adverse event of COVID-19 mRNA vaccination. With early recognition and diagnosis and supportive management, rhabdomyolysis has an excellent prognosis.

Keyphrases

coronavirus disease
sars cov
acute kidney injury
respiratory syndrome coronavirus
palliative care
emergency department